Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.
1 |
Amin AL et al. |
Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans.
|
2 |
Amin AL Olama A et al. |
Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci.
|
3 |
Annala M et al. |
Recurrent SKIL-activating rearrangements in ETS-negative prostate cancer.
|
4 |
Auvinen A, Tammela T. |
Mitä lääkärin ja potilaan tulee tietää eturauhassyövän seulonnasta?
|
5 |
Auvinen A, Tammela T. |
Mitä lääkärin tulee tietää eturauhassyövän seulonnasta?
|
6 |
Buzzoni C et al. |
Metastatic Prostate Cancer Incidence and Prostate-specific Antigen Testing: New Insights from the European Randomized Study of Screening for Prostate Cancer.
|
7 |
Cartwright R et al. |
Systematic review and metaanalysis of genetic association studies of urinary symptoms and prolapse in women.
|
8 |
Davies N et al. |
The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium.
|
9 |
Fischer D et al. |
MiRNA Profiles in Lymphoblastoid Cell Lines of Finnish Prostate Cancer Families.
|
10 |
Hakala T. |
Differentiated Thyroid Cancer: Diagnostics, prognostic factors and long-term outcome.
|
11 |
Heijnsdijk E et al. |
Cost-effectiveness of prostate cancer screening: a simulation study based on ERSPC data.
|
12 |
Hernesniemi J et al. |
Predicting sudden cardiac death using common genetic risk variants for coronary artery disease.
|
13 |
Huovinen S et al. |
Differential Isoform Expression and Selective Muscle Involvement in Muscular Dystrophies.
|
14 |
Järvinen R et al. |
Long-term Outcome of Patients with Frequently Recurrent Non-muscle-invasive Bladder Carcinoma Treated with One Perioperative Plus Four Weekly Instillations of Mitomycin C Followed by Monthly Bacillus Calmette-Guérin (BCG) etc.
|
15 |
Järvinen T et al. |
BMJ CONFIDENTIAL CLARE TAYLOR: ten minutes is not enougt Authors´reply to Lee and colleagues.
|
16 |
Kaapu K et al. |
Sotalol, but not digoxin is associated with decreased prostate cancer risk: A population-based case-control study.
|
17 |
Kaartinen IS et al. |
Reconstruction of the pelvic floor and the vagina after total pelvic exenteration using the transverse musculocutaneous gracilis flap.
|
18 |
Kallio J. |
Paikallisen munuaissyövän seuranta.
|
19 |
Kaukoniemi K et al. |
Epigenetically altered miR-193b targets cyclin D1 in prostate cancer.
|
20 |
Kilpeläinen T et al. |
The Finnish prostate cancer screening trial: analyses on the screening failures.
|
21 |
Kääriäinen M et al. |
Utilization of Three-Dimensional Computer-Aided Preoperative Virtual Planning and Manufacturing in Maxillary and Mandibular Reconstruction with a Microvascular Fibula Flap.
|
22 |
Laitinen V et al. |
Fine-mapping the 2q37 and 17q11.2-q22 loci for novel genes and sequence variants associated with a genetic predisposition to prostate cancer.
|
23 |
Lehto U-M et al. |
Eturauhassyöpäpotilaan puolisokin tarvitsee tukea.
|
24 |
Murtola TJ et al. |
Polymorphisms of Genes Involved in Glucose and Energy Metabolic Pathways and Prostate Cancer: Interplay with Metformin.
|
25 |
Ojala H et al. |
Elämänlaatu koetaan yksilöllisesti .
|
26 |
Oksala N, Puska P. |
Utilisation of validated risk prediction algorithms and wearable and automated systems may help to prevent serious adverse events.
|
27 |
Oksala N et al. |
Kindlin 3 (FERMT3) is associated with unstable atherosclerotic plaques, anti-inflammatory type II macrophages and upregulation of beta-2 integrins in all major arterial beds.
|
28 |
Osman NI et al. |
Open-label, 9-month extension study investigating the uro-selective alpha-blocker silodosin in men with LUTS associated with BPH.
|
29 |
Pashayan N et al. |
Reducing overdiagnosis by polygenic risk-stratified screening: findings from the Finnish section of the ERSPC.
|
30 |
Pöyhönen R et al. |
Non-iatrogenic civilian vascular trauma in a well-defined geographical region in Finland.
|
31 |
Raitoharju E et al. |
MicroRNAs in the atherosclerotic plaque .
|
32 |
Riikonen J, Kaipia A. |
Recent developments in minimally invasive radical prostatectomy.
|
33 |
Ryödi E et al. |
Cancer Incidence and Mortality in Patients Treated Either With RAI or Thyroidectomy for Hyperthyroidism.
|
34 |
Ryödi E et al. |
Cardiovascular morbidity and mortality in surgically treated hyperthyroidism - a nation-wide cohort study with a long-term follow-up.
|
35 |
Saad F et al. |
Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial.
|
36 |
Saarimäki L et al. |
Family history in the Finnish Prostate Cancer Screening Trial.
|
37 |
Scaravilli M et al. |
MiR-1247-5p is overexpressed in castration resistant prostate cancer and targets MYCBP2.
|
38 |
Sibolt G et al. |
Severe cerebral white matter lesions in ischemic stroke patients are associated with less time spent at home and early institutionalization.
|
39 |
Szulkin R et al. |
Genome-Wide Association Study of Prostate Cancer-Specific Survival.
|
40 |
Szulkin R et al. |
Prediction of individual genetic risk to prostate cancer using a polygenic score.
|
41 |
Thomsen FB et al. |
Survival benefit of early androgen receptor inhibitor therapy in locally advanced prostate cancer: long-term follow-up of the SPCG-6 study.
|
42 |
Isola J et al. |
Length of prostate biopsies is not necessarily compromised by pooling multiple cores in one paraffin block: an observational study.
|
43 |
Turpeinen H et al. |
A genome-wide expression quantitative trait loci analysis of proprotein convertase subtilisin/kexin enzymes identifies a novel regulatory gene variant for FURIN expression and blood pressure.
|
44 |
Umbehr M et al. |
Intraprostatic inflammation is positively associated with serum PSA in men with PSA <4?ng?ml(-1), normal DRE and negative for prostate cancer.
|
45 |
Uurto I et al. |
Muraglitazar-eluting bioabsorbable vascular stent inhibits neointimal hyperplasia in porcine iliac arteries.
|
46 |
Veitonmäki T et al. |
Use of non-steroidal anti-inflammatory drugs and prostate cancer survival in the finnish prostate cancer screening trial.
|
47 |
Violette PD et al. |
Decision aids for localized prostate cancer treatment choice: Systematic review and meta-analysis.
|
48 |
Wirth M et al. |
Prevention of bone metastases in patients with high-risk nonmetastatic prostate cancer treated with zoledronic acid: efficacy and safety results of the Zometa European Study (ZEUS).
|
49 |
Yen AM et al. |
Prostate cancer screening using risk stratification based on a multi-state model of genetic variants.
|
50 |
Ylipää A et al. |
Transcriptome Sequencing Reveals PCAT5 as a Novel ERG-Regulated Long Noncoding RNA in Prostate Cancer.
|